Tuesday, June 16, 2026

BA.3.2 Variant: Is This the New COVID-19 Threat for Asia?

The BA.3.2 COVID-19 variant is spreading globally, prompting health authorities to urge vaccinations for high-risk individuals.

Could a Trump Comeback Spell Disaster for U.S.-Asia Relations?

There are claims if former President Donald...

Rubio Says U.S. Respects South Korea’s Democratic Choice Amid Criticism From U.S. Lawmaker

Rubio defends South Korea's democratic choices amid claims of a leftward shift and emphasizes respect for its sovereignty.

Tag: market

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Volkswagen’s Audi Factory Plans: Will U.S. Tariff Changes Decide Their Fate?

Volkswagen's U.S. factory plans depend on tariff reductions; CEO Blume cites significant costs from past tariffs and calls for stable conditions.

How EverEx’s AI Solutions Are Transforming Musculoskeletal Care in the U.S. Market

EverEx is revolutionizing remote therapy monitoring in the U.S. with AI technology, aiming for a fivefold sales increase this year.

Unlock Youthful Skin: A Comprehensive Guide to Elabie Premier Fillers Launched in Thailand

Humedics launches Elavie Premier HA fillers in Thailand, marking significant expansion in Southeast Asia with a successful symposium.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Samsung’s AI Innovations: How the Bespoke Combo Washers are Redefining Laundry in 2026

Samsung Electronics showcases AI appliances at Best Buy, emphasizing innovation and premium branding in the U.S. market.

THE APPLE SCAM: Why The Most Criticized Phone On Earth Is Now Projected To Lead Until 2029

Apple is set to reclaim its title as the largest smartphone manufacturer, driven by strong iPhone 17 sales and market growth.

$1 Billion B2B Takeover: LG Appliance Quality Is So Flawless, US Homebuilders are Desperate for It

LG Electronics tops J.D. Power's consumer satisfaction survey for home appliances, excelling in multiple categories and enhancing market presence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.